Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy

OBJECTIVE: Mesenchymal stromal cells (MSCs) from adult bone marrow (BM) are considered potential candidates for therapeutic neovascularization in cardiovascular disease. When implementing results from animal trials in clinical treatment, it is essential to isolate and expand the MSCs under conditions following good manufacturing practice (GMP). The aims of the study were first to establish culture conditions following GMP quality demands for human MSC expansion and differentiation for use in clinical trials, and second to compare these MSCs with MSCs derived from culture in four media commonly used for MSC cultivation in animal studies simulating clinical stem cell therapy. MATERIAL AND METHODS: Human mononuclear cells (MNCs) were isolated from BM aspirates by density gradient centrifugation and cultivated in a GMP-accepted medium (EMEA medium) or in one of four other media. RESULTS: FACS analysis showed that the plastic-adherent MSCs cultured in EMEA medium or in the other four media were identically negative for the haematopoietic surface markers CD45 and CD34 and positive for CD105, CD73, CD90, CD166 and CD13, which in combined expression is characteristic of MSCs. MSC stimulation with vascular endothelial growth factor (VEGF) increased expression of the characteristic endothelial genes KDR and von Willebrand factor; the von Willebrand factor and CD31 at protein level as well as the capacity to develop capillary-like structures. CONCLUSIONS: We established culture conditions with a GMP compliant medium for MSC cultivation, expansion and differentiation. The expanded and differentiated MSCs can be used in autologous mesenchymal stromal cell therapy in patients with ischaemic heart disease.     

不同因子影响骨髓间充质干细胞的多向分化

背景：在组织工程领域,关于骨髓间充质干细胞定向诱导分化的研究越来越多,但是细胞培养基中不同成分会对骨髓间充质干细胞的体外增殖分化产生影响。目的：针对培养基中不同因子对骨髓间充质干细胞定向诱导分化的作用加以综述。方法：第一作者应用计算机检索1998年1月至2012年4月Pubmed数据库及万方数据库。检索英文关键词为“bone marrow mesenchymal stromal cells, cell culture medium, differentiation”,中文关键词为“骨髓间充质干细胞,细胞培养,定向诱导分化”,纳入有关不同因子对骨髓间充质干细胞向成骨细胞、软骨细胞和脂肪细胞定向诱导分化作用的文献,排除重复研究。结果与结论：计算机初检共得到184篇文献,根据纳入排除标准,对其中30篇文献进行综述。大体说来,骨髓间充质干细胞向成骨分化的主要因子有地塞米松、转化生长因子、维生素C、维生素D3、β-甘油磷酸钠及乙烯雌酚等;向软骨分化的主要因子有地塞米松、转化生长因子、维生素C、胰岛素样生长因子及成纤维细胞生长因子等;向脂肪细胞转化的主要因子有地塞米松、3-异丁基-1-甲基黄嘌呤、胰岛素和消炎痛等,但是其中一些因子的作用机制及不良反应还不明确,需要进一步的研究与验证。同时,骨髓间充质干细胞在骨髓中的含量较低,不同的分离方法会导致不同的分离率,因此如何选取一种分离率高的分离方法仍有待研究。     

多样本骨髓间充质干细胞分离培养方法的量化比较

目的比较不同方法获取骨髓间充质干细胞的效率,为其在组织工程的应用确立最佳培养方案。方法以3个月龄新西兰大白兔为实验对象,通过对全血培养法、溶血纯化法、密度梯度离心法进行比较性研究,对克隆形成率、首次传代时间、扩增成功率等指标进行比较。结果对克隆形成率和扩增成功率而言,溶血纯化方法最低传代时间为20.5d,全血培养方法有部分提高传代时间为(13.9±2.9)d;而密度梯度离心方法的效率最高,首次传代时间为(7.5±0.7)d。结论对于成年动物穿刺获取骨髓间充质干细胞而言,密度离心>全血培养>溶血纯化方法,明确了一种实用有效的骨髓间充质干细胞分离培养方法。     

Epigenetic conversion of human adult bone mesodermal stromal cells into neuroectodermal cell types for replacement therapy of neurodegenerative disorders

Tissue-specific stem cells, such as bone marrow-derived mesodermal stromal cells (MSCs), are thought to be lineage restricted and, therefore, could only be differentiated into cell types of the tissue of origin. Several recent studies, however, suggest that these types of stem cells might be able to break barriers of germ layer commitment and differentiate in vitro and/or in vivo into cells of different tissues, such as neuroectodermal cell types. Recently, protocols for high-yield generation of undifferentiated neural stem cell (NSC)-like cells from MSCs of primate and human origin were reported. Undifferentiated NSCs are commonly used and are more suitable for neurotransplantation compared with fully differentiated neural cells, as differentiated neural cells are well known to poorly survive detachment and subsequent transplantation procedures. These human MSC-derived NSC-like cells (MSC-NSCs) grow in neurosphere-like structures and express high levels of early neuroectodermal markers, but lose characteristics of MSCs. In the presence of selected growth factors, human MSC-NSCs can be differentiated into the three main neural phenotypes: astroglia, oligodendroglia and neurons. Compared with direct differentiation of human MSCs into mature neural cells, the conversion step seems to be essential to generate mature functional neuroectodermal cells. This review describes the techniques for the conversion of human MSCs into NSCs and summarises the data on epigenetic conversion of human MSCs into immature neuroectodermal cells. These cells provide a powerful tool for investigating the molecular mechanisms of neural differentiation, and might serve as an autologous cell source to treat acute and chronic neurodegenerative diseases.     

Influence of patient related factors on number of mesenchymal stromal cells reached after in vitro culture expansion for clinical treatment

Background: Number of stromal cells injected in patients with ischaemic heart disease (IHD) may be of importance for the treatment efficacy, which in turn may be influenced by various patient-related factors. In this study, we investigate whether patient-related factors influence the number of autologous stromal cells reached after in vitro culture expansion for clinical therapy.

Methods: Culture expansion data from 111 patients with IHD treated with autologous stromal cells in three clinical trials were used. We correlated the final cell count after two passages of cultivation with different patient factors.

Results: There was a significant relation between body mass index (BMI) and the number of adipose derived stromal cells (ASCs) reached after culture expansion and for all patients included into the three studies (r?=?0.375, p?=?.019 and r?=?0.200, p?=?.036, respectively). Moreover, there was a significantly higher number of ASCs reached in patients with hypertension compared to those without hypertension and for all patients overall (68.8?±?39.6?×?10⁶ vs. 39.1?±?23.6?×?10⁶, p?=?.020 and 62.0?±?55.0?×?10⁶ vs. 29.0?±?19.3?×?10⁶, p?<?.001, respectively). The same tendency was seen with bone marrow derived mesenchymal stromal cells (MSCs) in patients with hypertension compared to those without hypertension (58.4?±?61.8?×?10⁶ vs. 22.6?±?13.3?×?10⁶, p?<?.001) and in males compared to females (56.4?±?61.5?×?10⁶ vs. 30.9?±?27.9?×?10⁶, p?=?.041). Moreover, a significant negative correlation between left ventricular ejection fraction and number of MSCs was found (r?=??0.287, p?=?.017).

Conclusions: Patient related factors such as BMI, hypertension and gender may influence the number of MSCs reached after in vitro culture expansion.     

不同尿酸浓度对人骨髓间充质干细胞成神经分化的影响

背景：尿酸作为一种内源性的抗氧化剂,其抗氧化、抗 DNA 损害作用及发挥神经元保护作用近年受到关注。 目的：观察不同浓度尿酸对骨髓间充质干细胞成神经分化的影响。方法：体外分离、纯化、培养骨髓间充质干细胞,观察细胞形态,取扩增3代的骨髓间充质干细胞,分别用含0（对照组）、0.2,0.4,0.8 mmol/L浓度尿酸的预诱导液诱导24 h,再用含0（对照组）、0.2,0.4,0.8 mmol/L浓度尿酸的诱导液诱导1 h后行尼氏体染色,2 h后,用免疫组织化学法检测细胞内巢蛋白、神经元特异性烯醇化酶的表达。 结果与结论：骨髓间充质干细胞经诱导后,细胞胞体收缩,形成突起并形成连接。细胞胞质中存在蓝色颗粒状的尼氏体,含不同浓度尿酸的诱导组神经元特异性烯醇化酶阳性率均较对照组明显升高（P ＜0.05）,而且随着尿酸浓度增加,神经元特异性烯醇化酶阳性表达率逐渐增加（P ＜0.05）。含不同浓度尿酸的诱导组巢蛋白阳性表达率较对照组降低（P＜0.05）,诱导4 h后,细胞脱落明显。在体外一定时间内,尿酸能够促进骨髓间充质干细胞向神经元样细胞的分化,且具有一定的浓度依赖性。     

成人骨髓间充质干细胞体外定向诱导分化为神经元样细胞的研究

目的研究人骨髓间充质干细胞（mesenchymal stem cells，MSCs）向神经细胞分化的可能性。方法利用Per-coil梯度分离及贴壁筛选法分离培养和扩增MSCs；利用bFGF、化学诱导剂DMSO和BHA联合诱导MSCs向神经元转化，观察分化过程中细胞形态的变化，利用免疫细胞化学和RT-PCR方法检测神经元特异性标志物的表达情况。结果经Perecoll梯度分离及贴壁筛选法获得了纯度较高的人MSCs，诱导分化后的细胞呈现双极、多极和锥形的典型神经元细胞的形态，并且分别从mRNA和蛋白水平上证明诱导分化后的细胞表达神经元标记物NSE和NF，不表达神经胶质细胞标记物GFAP。结论人MSCs可以在体外诱导分化为神经元样细胞，这种潜能使其有可能成为神经系统疾病细胞移植治疗的种子细胞。     

Whatever their differentiation status,human progenitor derived – or mature – endothelial cells induce osteoblastic differentiation of bone marrow stromal cells

Association of the bone‐forming osteoblasts (OBs) and vascular endothelial cells (ECs) into a biomaterial composite provides a live bone graft substitute that can repair the bone defect when implanted. An intimate functional relationship exists between these cell types. This communication is crucial to the coordinated cell behaviour necessary for bone development and remodelling. Previous studies have shown that direct co‐culture of primary human osteoprogenitors (HOPs) with primary human umbilical vein endothelial cells (HUVECs) stimulates HOPs differentiation and induces tubular‐like networks. The present work aims to test the use of human bone marrow stromal cells (HBMSCs) co‐cultured with human endothelial progenitor cells in order to assess whether progenitor‐derived ECs (PDECs) could support osteoblastic differentiation as mature ECs do. Indeed, data generated from the literature by different laboratories considering these co‐culture systems appear difficult to compare. Monocultures of HUVECs, HOPs, HBMSCs (in a non‐orientated lineage), PDECs (from cord blood) were used as controls and four combinations of co‐cultures were undertaken: HBMSCs–PDECs, HBMSCs–HUVECs, HOPs–PDECs, HOPs–HUVECs with ECs (mature or progenitor) for 6 h to 7 days. At the end of the chosen co‐culture time, intracellular alkaline phosphatase (ALP) activity was detected in HOPs and HBMSCs and quantified in cell extracts. Quantitative real‐time polymerase chain reaction (qPCR) of ALP was performed over time and vascular endothelial growth factor (VEGF) was measured. After 21 days, calcium deposition was observed, comparing mono‐ and co‐cultures. We confirm that ECs induce osteoblastic differentiation of mesenchymal stem cells in vitro. Moreover, HUVECs can be replaced by PDECs, the latter being of great interest in tissue engineering. Copyright © 2012 John Wiley & Sons, Ltd.     

Adult mesenchymal stromal stem cells for therapeutic applications

Mesenchymal stromal stem cells (MSC) can be found in almost any adult organ. They can be isolated and expanded within several weeks up to hundreds of millions of cells. The cell isolation based on the surface antigen expression may significantly enrich for the desired cell population and reduce the time required for cell expansion. MSC display a unique molecular signature which clearly discriminates them from other stem cell types. MSC can be differentiated into the cells of several lineages. Additionally, the unique biological properties of MSC are mediated by strong immunomodulatory activity and by paracrine mechanisms. Potential therapeutic applications of the cells require clinically compliant protocols for cell isolation and expansion. The therapeutic utility of MSC has been evaluated and found to be useful in several pre‐clinical animal models as well as in clinical trials.     

胚胎及骨髓间充质干细胞增殖活性与成脂分化能力的比较

背景：间充质干细胞最先在骨髓中发现,且骨髓间充质干细胞的相关研究也最多,但是骨髓间充质干细胞来源有限且含量极低。近年来,已经从人胚胎组织分离出间充质干细胞,其与骨髓间充质干细胞在生物学特性上有很多相似之处,但是二者的成脂诱导能力比较尚无明确报道。目的：比较人胚胎组织与骨髓来源间充质干细胞体外增殖能力及成脂诱导能力。方法：采用全骨髓法获得骨髓间充质干细胞,胶原酶消化法获得胚胎组织间充质干细胞。流式细胞术鉴定两种间充质干细胞表面分子标记。用细胞计数方法检测两种间充质干细胞增殖能力。分别向两种细胞培养体系中加入成脂诱导剂诱导14d,经油红O染色后观察并计数,计算不同来源间充质干细胞的成脂诱导分化率。结果与结论：从两种不同组织中均可获取梭形贴壁的间充质干细胞,表面标记物CD44、CD73、CD90和CDl05均呈阳性表达,CDl4、CD34和CD45均为阴性表达;胚胎组织间充质干细胞的增殖能力明显强于骨髓间充质干细胞（P〈0．01）。胚胎组织间充质干细胞和骨髓间充质干细胞经过成脂诱导液诱导14d后,油红O染色结果均为阳性,但是骨髓间充质干细胞体外成脂能力明显强于胚胎组织间充质干细胞（P〈0．01）。     

Large‐scale expansion of pre‐isolated bone marrow mesenchymal stromal cells in serum‐free conditions

The regenerative potential of mesenchymal stromal or stem cells (MSCs) has generated tremendous interest for treating various degenerative diseases. Regulatory preference is to use a culture medium that is devoid of bovine components for stem cell expansion intended for therapeutic applications. However, a clear choice an alternative to fetal bovine serum (FBS) has not yet emerged. We have screened five different commercially available serum‐free media (SFM) for their ability to support the growth and expansion of pre‐isolated undifferentiated bone marrow‐derived MSCs (BM‐MSCs) and compared the results with cells grown in standard FBS‐containing medium as control. In addition, based on initial screening results, BD Mosaic? Mesenchymal Stem Cell Serum‐free (BD‐SFM) medium was evaluated in large‐scale cultures for the performance and culture characteristics of BM‐MSCs. Of the five different serum‐free media, BD‐SFM enhanced BM‐MSCs growth and expansion in Cell STACK (CS), but the cell yield per CS‐10 was less when compared to the control medium. The characteristics of MSCs were measured in terms of population doubling time (PDT), cell yield and expression of MSC‐specific markers. Significant differences were observed between BD‐SFM and control medium in terms of population doublings (PDs), cell yield, CFU‐F and morphological features, whereas surface phenotype and differentiation potentials were comparable. The BD‐SFM‐cultured MSCs were also found to retain the differentiation potential, immune‐privileged status and immunosuppressive properties inherent to MSCs. Our results suggest that BD‐SFM supports large‐scale expansion of BM‐MSCs for therapeutic use. Copyright © 2014 John Wiley & Sons, Ltd.     

人脐血中分离骨髓间充质干细胞成骨诱导前后的生物学特性

目的观察诱导因素对骨髓间充质干细胞向成骨方向分化的影响,探索骨组织工程的种子细胞来源。方法使用密度梯度离心法分离来源于人脐血的骨髓间充质干细胞进行培养,保留已贴壁细胞传代,观察在加有地塞米松、维生素C、β-甘油磷酸钠的培养液中骨髓间充质干细胞的生长及分化情况。结果分离得到的骨髓间充质干细胞呈成纤维样表现,诱导条件下第2代细胞碱性磷酸酶活性增高,12d达到最高,为(33.10±0.54)U/ml,P<0.001,t=-48.32,且出现矿化结节。结论人脐血来源的骨髓间充质干细胞在诱导培养液作用下具有一定的成骨能力,可作为骨组织工程种子细胞。     

颅骨来源骨髓基质干细胞的分离培养方法

背景：从小鼠颅骨提取的一类骨髓基质干细胞称为PA6细胞,研究者发现当PA6细胞与其他干细胞共培养时可向神经细胞分化,此特性可被应用于神经损伤部位的修复。所以,PA6细胞越来越受到研究者的关注,但目前国内对类似骨髓基质干细胞PA6的提取方法鲜见报道。目的：分离培养SD大鼠颅骨来源的骨髓基质干细胞,体外观察细胞形态并免疫荧光鉴定。方法：无菌条件下,取新生的SD大鼠颅骨将其剪碎,用含体积分数为10%胎牛血清的DMEM培养液冲洗颅骨碎片,反复吹打制成单细胞悬液,将其置于培养瓶中培养,多次换液培养纯化细胞。取第2代生长均一的细胞,倒置显微镜下观察细胞形态,并用免疫荧光染色法进行细胞表面标记鉴定。结果与结论：原代细胞培养24 h后,骨髓基质干细胞开始贴壁;3 d后细胞数量增多,形态呈不规则形、多角形、三角形和扁平形;细胞传代后,形态基本均一,细胞排列呈放射状和束状,贴壁能力较强,部分细胞呈聚集生长,增殖速度比原代有明显的加快。免疫荧光染色检测CD105、CD73、CD44、CD90表达呈阳性, CD45、CD34、CD14和HLA-DR表达呈阴性,证实了提取的细胞为骨髓基质干细胞。     

猪骨髓间质干细胞的分离培养及分化潜能的鉴定

目的：建立猪骨髓间质干细胞(MSCs)的体外分离培养和鉴定的方法，探讨体外培养的间充质干细胞的一些生物学特点，为利用猪的实验研究提供实验基础。方法：猪的髂嵴穿刺吸取骨髓，经密度梯度离心得到骨髓单个核细胞，接种后形成单层贴壁的成纤维样的细胞。检测细胞周期，多向诱导分化鉴定分离的细胞。结果：体外培养的原代MSCs12～14d达到融合，传代后仍具有分化成骨的能力，细胞周期显示有80％的细胞处于GO／G1期。结论：体外培养猪的MSCs具有分化成骨的潜能，生长稳定，传代后仍保持未分化状态．猪骨髓间充质干细胞分离培养体系的建立为基础研究和组织工程提供了一个有价值的动物模型。     

自体骨髓间充质干细胞移植治疗急性心肌梗死临床观察

目的探讨自体骨髓间充质干细胞经冠状动脉途径移植治疗急性心肌梗死的临床疗效。方法 NYHA心功能Ⅱ～Ⅳ级且心肌存在灌注缺损、拟择期行介入治疗术的急性心肌梗死患者36例,随机分为观察组17例和对照组19例,2组介入治疗术后分别通过大腔导管于梗死相关血管内注入等量骨髓间充质干细胞和生理盐水;于介入治疗术前、术后1,3个月行24h动态心电图、静息心脏超声心动图及99mTeSPECT检查进行疗效及风险评价。结果观察组左心室舒张末期内径术后3个月时较术前和术后1个月时均明显减小（P〈0.05）,对照组手术前、后差异无统计学意义（P〉0.05）;观察组左心室射血分数术后1,3个月时均较术前和同期对照组明显增加（P〈0.05）,对照组术后3个月较术前明显增大（P〈0.05）;观察组灌注缺损面积百分比术后3个月时较术前和术后1个月时均明显减小（P〈0.05）,对照组术后3个月与术前比较差异有统计学意义（P〈0.05）;术后3个月2组左心室舒张末期内径、左心室射血分数及灌注缺损面积百分比比较差异均有统计学意义（P〈0.05）;2组恶性临床事件比较差异无统计学意义（P〉0.05）。结论自体骨髓间充质干细胞移植治疗急性心肌梗死是相对有效安全的。     

兔骨髓间充质干细胞分离培养后的活力检测

背景：目前分离纯化骨髓间充质干细胞多采用单一的方法,对扩增培养过程中细胞活力的变化没有较为系统而全面的评估。目的：探索体外分离培养和纯化兔骨髓间充质干细胞的方法,并对细胞的活力进行检测。方法：采用密度梯度离心联合贴壁筛选的方法分离纯化兔骨髓间充质干细胞,从形态学、细胞表型和成骨成脂能力方面进行鉴定;并从细胞生长曲线、贴壁率和克隆形成率3个方面评估细胞活力。结果与结论：原代细胞多呈梭形和圆形,48h后大部分细胞贴壁,8-10d细胞融合达80%-90%,传代周期为3-5d;流式检测显示CD14、CD34和CD45表达阴性,CD29、CD44和CD90表达阳性;成骨诱导茜素红染色可见明显的钙结节,成脂诱导油红O染色可见大量脂肪细胞;细胞生长曲线、贴壁率及克隆形成率的结果表明第1代和第3代细胞的活力优于第5代细胞。结果说明密度梯度离心联合贴壁筛选的方法能够有效的分离纯化骨髓间充质干细胞,并能较好的保持其生物功能,在扩增传代过程中,细胞活力会有不同程度的下降。     

Allogenic bone-marrow-derived mesenchymal stem cells transplantation as a novel therapy for systemic lupus erythematosus

Importance of the field: Bone-marrow-derived mesenchymal stem cells (BMMSC) are multipotent non-hematopoietic progenitor cells that are being explored as a promising new treatment for tissue regeneration. Although their immunomodulatory properties are not yet completely understood, their low immunogenic potential together with their effects on immune response make them a promising therapeutic tool for severe refractory autoimmune diseases including systemic lupus erythematosus (SLE).

Area covered in this review: Our aim is to discuss recent progress in understanding the role of malfunctioning BMMSC in etiopathogenesis of SLE and to explore allogenic BMMSC transplantation as a potential therapy for SLE.

What the reader will gain: Recent evidence suggests that the functions of BMMSC are disrupted in SLE pathology. This malfunction may result as a corollary of the disease, or may play a more fundamental role in its etiopathogenesis. We provide a brief characterization of BMMSC immunomodulatory effects, and describe our current understanding of the mechanisms by which it plays a part in treating SLE. We also present our clinical trial using allogenic BMMSC in this context.

Take home message: Allogenic BMMSC appear to be a safe therapeutic option for treatment-resistant SLE as illustrated in our clinical trial.     

Characterization of endothelial-like cells derived from human mesenchymal stem cells

BACKGROUND: Blood-derived endothelial progenitor cells (EPC) have been used to treat ischemic disease. However, the number of EPC that can be obtained from adult blood is limited. OBJECTIVE: To characterize endothelial-like cells obtained from human bone marrow and determine their ability to stimulate new blood vessel formation in vivo. METHODS: Mononuclear cells (MNC) were isolated from human bone marrow or umbilical cord blood and cultured in endothelial growth medium (EGM-2). Mesenchymal stem cells (MSC) were isolated from bone marrow and induced to differentiate into endothelial-like cells (MSCE), or adipocytes or osteocytes by growth in EGM-2, adipogenic or osteogenic medium. RESULTS: Cells obtained by culturing bone marrow MNC in EGM-2 formed cord- or tube-like structures when grown on Matrigel(TM) and expressed several endothelial marker proteins. However, cell morphology and the profile of endothelial marker protein expression were different from those of cord blood-derived EPC (cbEPC). Cells with a similar phenotype were obtained by differentiation of MSC into MSCE, which was accompanied by an increase of endothelial marker proteins and a diminished capacity to differentiate into adipocytes. Subcutaneous implantation of MSCE in collagen plugs in non-obese diabetic-severe combined immunodeficient (NOD-SCID) mice resulted in formation of functional blood vessels that had incorporated the MSCE. CONCLUSIONS: Our results show that MSCE and cbEPC are different cell types. The formation of functional blood vessels by MSCE, combined with high yields and a reduced capacity to differentiate into other cell types compared with MSC, makes these cells potentially useful for autologous therapy of ischemic disease.     

体外诱导人骨髓间充质干细胞向造血细胞分化的研究

目的探讨体外诱导人骨髓间充质干细胞（hMSC）向造血细胞分化的可行性及分化条件。方法首先建立hMSC的分离培养扩增体系，制备小鼠胎肝基质细胞条件培养液（FLSC-CM），将hMSC接种在分别含FLSC-CM和IL-6、SCF组合的培养体系中，通过形态学、直接免疫荧光染色检测法、粒-单／巨噬系集落形成细胞培养（CFU-GM）对分化细胞进行鉴定。结果hMSC经FISC—CM诱导培养9天后，产生较多的悬浮细胞，悬浮细胞瑞士染色后形态类似于单核或小淋巴细胞，表达人CD34和人CD45表面抗原。且能够形成造血祖细胞集落（CFU-GM）。结论FLSC-CM可诱导hMSC分化为具有造血干／祖细胞特性的前体细胞。     

人骨髓间质干细胞分离纯化及基本生物学特性研究

目的　分离纯化人骨髓间质干细胞 (MSC) ,研究其基本生物学特性。方法　用比密 1 .0 73Ficoll淋巴细胞分离液分离成人骨髓MSC ,体外扩增 ,观察细胞生长特性 ,流式细胞仪检测骨髓MSC表面抗原表达及细胞周期 ,染色体技术分析骨髓MSC遗传特性。结果　成人骨髓MSC培养 3d后有散在呈针尖状的贴壁细胞 ,7～ 1 0d后形成集落或融合呈纤维状 ;体外扩增原代可获得 (4～ 6 )× 1 0 5个细胞 ,1 0代可获得 (1～ 5 )× 1 0 1 0 个细胞 ,5～ 6代以后的细胞增殖能力下降 ;流式细胞仪检测结果显示 :CD1 3、CD2 9、CD4 4、CD71表达阳性 ,CD3、CDl4、CD33、CD34、CD38、CD4 5、HLA DR不表达 ;染色体核型正常 ;细胞周期分析显示 ,G0 /G1 期 :79.4 8% ,G2 /M期 :6 .1 0 % ,S期 :1 4 .4 2 %。结论　人骨髓MSC体外具有较好的增殖更新能力 ,3～ 6代的人骨髓MSC作为组织工程细胞具有广阔的应用前景